Annual Report

Overview

The report describes ESG performance for the Group’s PRC pharmaceutical distribution operations, excluding Hong Kong because it is considered insignificant. The Board oversees ESG matters and an ESG working team collects and analyses data. The report also conducts a stakeholder materiality assessment and reports 73.0 tCO2e of total GHG emissions, 44.9 Tonnes of non-hazardous waste disposal and 700.0 m3 of water consumption for 2023.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services